Table 4.
Peak intratidal NO concentrations in the artificial trachea resulting from different modes and sites of NO administration
| Delivery mode | Flow proportional | Continuous | Pulsed | |
|---|---|---|---|---|
| Injection site relative to y-piece | ||||
| Target [NO] | Distant | Distant | Distant | Close |
| 5 ppm | 6.27 ± 1.22 | 8.1 ± 2.59 | 8.73 ± 3.41 | 17.83 ± 5.66 |
| 10 ppm | 12.22 ± 2.58 | 14.81 ± 4.62 | 16.15 ± 5.64 | 29.4 ± 6.27 |
| 20 ppm | 23 ± 3.69 | 31.02 ± 9.92 | 33.35 ± 13.45 | 73.11 ± 24.25 |
| 40 ppm | 45.21 ± 7.1 | 59.57 ± 20 | 68.4 ± 30.14 | 147.73 ± 38.1 |
NO was administered via “flow proportional” or “continuous delivery” through injection into the breathing circuit at 20 cm after the mechanical ventilator (distant to y-piece), or via pulsed delivery with injection distant or close to (i.e. 10 cm proximal of) the y-piece, sampled from a mid-tracheal sampling site, and quantified with ozone-based chemiluminescence. For each NO target concentration, mechanical ventilation was performed with ultra-low (230 ml), low (450 ml) or traditional (750 ml) tidal volumes applied via both pressure (PCV) and volume-controlled ventilation (VCV) with I:E ratios of 1:1 and 1:1.9 (12 conditions). Peak intratidal NO concentrations in the trachea were determined over a period of 120 s (n = 30 respiratory cycles) per each individual ventilation condition (i.e. n = 360 per tabular cell representing 12 ventilation conditions). Means ± SD